Efficacy of Sorafenib for the Treatment of Post-Transplant Hepatocellular Carcinoma Recurrence

BACKGROUND: The role of sorafenib in patients with hepatocellular carcinoma (HCC) recurrence after liver transplantation (LT) has been rarely studied. The aim of this study was to evaluate the efficacy of sorafenib in post-LT era. METHODS: Consecutive patients with post-transplant HCC recurrence not...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Korean Med Sci
Autores principales: Kang, Seong Hee, Cho, Hyeki, Cho, Eun Ju, Lee, Jeong-Hoon, Yu, Su Jong, Kim, Yoon Jun, Yi, Nam-Joon, Lee, Kwang-Woong, Suh, Kyung-Suk, Yoon, Jung-Hwan
Formato: Artigo
Lenguaje:Inglês
Publicado: The Korean Academy of Medical Sciences 2018
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6209769/
https://ncbi.nlm.nih.gov/pubmed/30402048
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2018.33.e283
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares